Search Results - "Campar, Ana"

Refine Results
  1. 1

    Glycans as Key Checkpoints of T Cell Activity and Function by Pereira, Márcia S, Alves, Inês, Vicente, Manuel, Campar, Ana, Silva, Mariana C, Padrão, Nuno A, Pinto, Vanda, Fernandes, Ângela, Dias, Ana M, Pinho, Salomé S

    Published in Frontiers in immunology (27-11-2018)
    “…The immune system is highly controlled and fine-tuned by glycosylation, through the addition of a diversity of carbohydrates structures (glycans) to virtually…”
    Get full text
    Journal Article
  2. 2

    Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome by Caley, Lídia, Campar, Ana, Mendonça, Teresa, Farinha, Fátima

    “…Classical Ehlers-Danlos syndrome (cEDS) is one of the 13 subtypes of Ehlers-Danlos syndrome, which has the major clinical criteria of hyperextensibility skin,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Orthostatic hypotension as an unusual presentation of spinal calcium pyrophosphate deposition disease: case report and review of literature by De Azevedo Sofia Moura, Pichel Rita Carrilho, Freitas Egídio, Campar Ana, Marinho António, Mendonça Teresa

    Published in Romanian Journal of Internal Medicine (01-12-2023)
    “…Calcium pyrophosphate crystal deposition disease (CPPD), also known as pseudogout, with spinal involvement, is associated with clinical manifestations of acute…”
    Get full text
    Journal Article
  5. 5

    Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis by Campar, Ana, Alves, Inês, Santos-Pereira, Beatriz, Nogueira, Rafaela, Pinto, Miguel Mendonça, Vasconcelos, Carlos, Pinho, Salomé S.

    Published in iScience (21-07-2023)
    “…Idiopathic inflammatory myopathies (IIM) are a group of chronic autoimmune diseases mainly affecting proximal muscles. Absence of meaningful prognostic factors…”
    Get full text
    Journal Article
  6. 6

    Primary Sjögren's syndrome activity and damage indices comparison by Campar, Ana, Isenberg, David A.

    Published in European journal of clinical investigation (01-07-2010)
    “…Eur J Clin Invest 2010; 40 (7): 636–644 Background  Significant differences exist in outcome measures developed to assess patients with primary Sjögren’s…”
    Get full text
    Journal Article
  7. 7

    Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports by Pinheiro, Guiomar, Costa, Ana Rita, Campar, Ana, Mendonça, Teresa

    “…Fasciitis with eosinophilia (FE) is a rare connective tissue disease. Due to its rarity, large-scale studies are lacking, which makes its treatment…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome by Caley, Lídia, Campar, Ana, Mendonça, Teresa, Farinha, Fátima

    “…Classical Ehlers-Danlos syndrome (cEDS) is one of the 13 subtypes of Ehlers-Danlos syndrome, which has the major clinical criteria of hyperextensibility skin,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Refractory disease in Systemic Lupus Erythematosus by Campar, Ana, Farinha, Fátima, Vasconcelos, Carlos

    Published in Autoimmunity reviews (01-09-2011)
    “…Abstract There is no definition or guidelines for refractory disease (RD) in Systemic Lupus Erythematosus (SLE). However, new therapies have been tested mainly…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Immunoglobulin G4 Related-Disease: A Rare Presentation With Secondary Hypereosinophilic Syndrome and Eosinophilic Ascites by Serpa Pinto, Luisa, Lamas, Nuno Jorge, Campar, Ana, Ferreira, Alvaro, Cruz, Ana Rita

    Published in Journal of medical cases (2021)
    “…Immunoglobulin G4 related-disease (IgG4-RD) is a multisystemic immune-mediated fibroinflammatory disease, with a strong predilection for salivary and lacrimal…”
    Get full text
    Journal Article
  17. 17

    Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection by Moura, João, Duarte, Sara, Sardoeira, Ana, Neves-Maia, João, Damásio, Joana, Taipa, Ricardo, Carneiro, Paula, Neves, Esmeralda, Campar, Ana, Santos, Ernestina

    Published in Neurohospitalist (01-04-2022)
    “…Introduction There is a complex interplay between systemic autoimmunity, immunosuppression, and infections. Any or all of these can result in neurologic…”
    Get full text
    Journal Article
  18. 18

    Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: a management challenge by Furtado, Inês, Pinheiro, Guiomar, Campar, Ana, Mendonça, Teresa

    Published in BMJ case reports (04-06-2018)
    “…Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disorder. Neuromyelitis optica (NMO) is an infrequent neuroinflammatory disorder, whose…”
    Get full text
    Journal Article
  19. 19

    P117 Rituximab therapy for primary Sjögren’s syndrome – a retrospective single-centre study by Figueiras, Mariana, Sousa, Filipa, Brandão, Mariana, Oliveira, Daniel, Faria, Raquel, Campar, Ana, Almeida, Isabel, Marinho, António, Farinha, Fátima, Vasconcelos, Carlos

    Published in Lupus science & medicine (01-03-2020)
    “…BackgroundThe rationale for B cell depletion therapy with rituximab (RTX) in primary Sjögren’s syndrome (pSS) relies upon the well-established role of B cell…”
    Get full text
    Journal Article
  20. 20

    P116 Outcomes and safety of rituximab use in systemic lupus erythematosus – a single-centre analysis by Oliveira, Daniel G, Faria, Raquel, Pereira, Flávio, Faria, Luciana, Campar, Ana, Brandão, Mariana, Almeida, Isabel, Marinho, António, Farinha, Fátima, Vasconcelos, Carlos

    Published in Lupus science & medicine (01-03-2020)
    “…Background/PurposeRituximab (RTX) has been used worldwide in moderate to severe Systemic Lupus Erythematosus (SLE), despite failure in clinical trials. We…”
    Get full text
    Journal Article